Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Januar 2018

Planlagt Fastgjort Låst Flyttet Genmab
2.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • M Offline
    M Offline
    Mcjean
    wrote on sidst redigeret af
    #1168

    Som jeg skrev i går nu begynder processen for den nye blockbuster at tage form, stille og roligt, små pip hist og pist, der bygges op til en ny fest med enormt potentiale og når pippene bliver store nok skal analytikerne frem med kuglerammen, denne aktie er potent som en i h..........!

    1 Reply Last reply
    0
    • R Offline
      R Offline
      Repsac
      wrote on sidst redigeret af
      #1169

      godt man ikke er short i den......

      1 Reply Last reply
      0
      • royalR Offline
        royalR Offline
        royal
        wrote on sidst redigeret af
        #1170

        All that glitters is not gold.

        1 Reply Last reply
        0
        • G Offline
          G Offline
          gentogen
          wrote on sidst redigeret af
          #1171

          Apropos RA, så kan man på Clinical Trials om 2 fase 3 studier (!) læse følgende:"Terminated (Ofatumumab IV trials in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery".

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #1172

            Lige præcis det der får mig til at spørge Winkel om ikke studierne i sc ofa Ra skal genoptages.

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #1173

              The National Institute for Health and
              Care Excellence (NICE) is backing NHS use of Janssen’s Darzalex via the Cancer Drugs Fund (CDF) for some adults with previously treated multiple myeloma. http://www.pharmatimes.com/news/nice_approves_cdf_funding_for_janssens_darzalex_1217463

              1 Reply Last reply
              0
              • O Offline
                O Offline
                OHW
                wrote on sidst redigeret af
                #1174

                705 patienter pr. år..

                1 Reply Last reply
                0
                • O Offline
                  O Offline
                  OHW
                  wrote on sidst redigeret af
                  #1175

                  Det var nok derfor, der kom lidt liv i aktien opad, indtil det gik op for folk, at det ikke var en komplet godkendelse..

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #1176

                    It is a good step in the right direction, I had already noticed NICE had unfortunately moved the Expected publication date on Daratumumab with bortezomib from June to 24 October 2018, so I am glad we get something going in the UK

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #1177

                      Nurses need to be trained, process explained etc, MDs can start using it and see the results, so that hopefully when real approval comes it can pick up fast.

                      1 Reply Last reply
                      0
                      • O Offline
                        O Offline
                        OHW
                        wrote on sidst redigeret af
                        #1178

                        Det betyder ikke så meget for kursen men forhåbenligt rigtigt meget for de patienter der får glæde af dara.

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #1179

                          700 patients still represent a nice amount of revenue if we can get them this year...

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            GeorgeBest
                            wrote on sidst redigeret af
                            #1180

                            Ufatteligt at Celgene vil betale 8-10 milliarder USD for Juno. Både Kite og Novartis er jo længere fremme. Også til noget der kun kan bruges i den meget sene linier! https://medwatch.dk/Medicinal___Biotek/article10210882.ece?utm_campaign=Middag&utm_content=2018-01-17 12%3A16%3A32&utm_medium=top&utm_source=Feed

                            1 Reply Last reply
                            0
                            • M Offline
                              M Offline
                              mobbyduck1
                              wrote on sidst redigeret af
                              #1181

                              det er helt sygt, svært at forstå motivationen

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                mobbyduck1
                                wrote on sidst redigeret af
                                #1182

                                og prisen

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #1183

                                  Aner man en smule sarkasme GB? 🙂

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    GeorgeBest
                                    wrote on sidst redigeret af
                                    #1184

                                    Nej jeg forstår det virkelig ikke. Hvis det kun er til de sene linier, er det jo en hel opskur pris. Og hvornår får de noget på markedet?

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      GeorgeBest
                                      wrote on sidst redigeret af
                                      #1185

                                      Juno is currently recruiting for a phase 1 trial combining its BCMA-directed CAR-T therapy in combination with Revlimid, and has also just signed a licensing deal with Lilly on its myeloma CAR-T candidate. https://pharmaphorum.com/news/celgene-talks-buy-car-t-partner-juno/

                                      1 Reply Last reply
                                      0
                                      • G Offline
                                        G Offline
                                        GeorgeBest
                                        wrote on sidst redigeret af
                                        #1186

                                        Phase 1???

                                        1 Reply Last reply
                                        0
                                        • M Offline
                                          M Offline
                                          mobbyduck1
                                          wrote on sidst redigeret af
                                          #1187

                                          hvis de betaler omkring 10 mia USD er det præcist, hvad samtlige aktier i Genmab er værd pt. Det virker sgu da helt sygt, og som GB siger, hvornår begynder man at få skillinger i kassen, vel der kommer til at gå meget lang tid!

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger